Axxcess Wealth Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,518
| Closed | -$37.7K | – | 944 |
|
|
2023
Q4 | $37.7K | Hold |
3,518
| – | – | ﹤0.01% | 817 |
|
|
2023
Q3 | $21.1K | Hold |
3,518
| – | – | ﹤0.01% | 791 |
|
|
2023
Q2 | $24.3K | Hold |
3,518
| – | – | ﹤0.01% | 580 |
|
|
2023
Q1 | $55.2K | Hold |
3,518
| – | – | ﹤0.01% | 621 |
|
|
2022
Q4 | $70.4K | Sell |
3,518
-875
| -20% | -$17.5K | 0.01% | 599 |
|
|
2022
Q3 | $78K | Hold |
4,393
| – | – | 0.01% | 525 |
|
|
2022
Q2 | $98K | Hold |
4,393
| – | – | 0.01% | 514 |
|
|
2022
Q1 | $122K | Buy |
4,393
+875
| +25% | +$24.3K | 0.01% | 607 |
|
|
2021
Q4 | $160K | Buy |
+3,518
| New | +$160K | 0.01% | 597 |
|